Rainbow Childrens Medicare Limited has informed the Exchange regarding Appointment of Mr Santanu Mukherjee as Non- Executive Independent Director of the company w.e.f. October 22, 2026.
RAINBOW · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Rainbow Children's Medicare Limited held its Board meeting on May 23, 2026, approving audited standalone and consolidated financial results for Q4 and FY ended March 2026 with an unmodified opinion from S.R. Batliboi & Associates LLP. The Board recommended a final dividend of ₹3.5 per equity share (35% on ₹10 face value), subject to shareholder approval at the 28th AGM scheduled for July 29, 2026, with record date July 21, 2026. Key appointments include re-appointment of Dr. Ramesh Kancharla as Chairman and Managing Director and Dr. Dinesh Kumar Chirla as Whole Time Director for five-year terms starting August 11, 2026. Additionally, Mr. Santanu Mukherjee and Ms. Sundari R. Pisupati were re-appointed as Independent Directors for second five-year terms. M/s. Lavanya & Associates LLP was re-appointed as Cost Auditors for FY 2026-27. Note: The headline refers to an appointment date of October 22, 2026 for Mr. Santanu Mukherjee, which is a future effective date for his second term commencement.
The filing reflects stable governance with continuity in leadership and a shareholder-friendly dividend recommendation. Clean audit results and re-appointment of key management personnel should be viewed positively by investors.